B. infantis EVC001

OTHER3 trials

Sponsors

Evolve BioSystems, Inc.

Conditions

Gut MicrobiomeInfant Gut MicrobiomePreterm Infant

Unknown Phase

Rescuing the Microbiome Effectively With Different Doses of B. Infantis in Infants

CompletedNCT03476447

Evolve BioSystems, Inc.Gut Microbiome

Start: 2018-04-06End: 2019-04-03Updated: 2019-04-19

The FOUNDATION Study

CompletedNCT03939546

Evolve BioSystems, Inc.Preterm Infant

Start: 2019-07-03End: 2021-06-01Updated: 2021-06-30

The EFFECT Study: Probiotic and HMO Supplementation in Infants

CompletedNCT03994315

Evolve BioSystems, Inc.Infant Gut Microbiome

Start: 2019-09-12End: 2020-03-13Updated: 2020-07-09

Related Papers

Randomized, placebo-controlled trial reveals the impact of dose and timing of <i>Bifidobacterium infantis</i> probiotic supplementation on breastfed infants' gut microbiome.

2025-12-22

B. infantis EVC001 Is Well-Tolerated and Improves Human Milk Oligosaccharide Utilization in Preterm Infants in the Neonatal Intensive Care Unit

Frontiers in Pediatrics2022-01-0517 citations